IC50 Calculator
IC50 represents the concentration at which a substance exerts half of its maximal inhibitory effect. This value is typically used to characterize an antagonist of a biological process (ex. phosphorylation). In pharmacology, it is an important measure of potency for a given agent. Traditionally, this value is expressed as a molar concentration.
This calculator generates an IC50 value typically thought of as the relative IC50. For technical assistance on using this calculator, please contact websupport@aatbio.com.
This tool has recently been updated.
This calculator generates an IC50 value typically thought of as the relative IC50. For technical assistance on using this calculator, please contact websupport@aatbio.com.
This tool has recently been updated.
How to use this tool
1. Paste experimental data into the box on the right. Data can be copied directly from Excel columns. Data can also be comma-separated, tab-separated or space-separated values. If entering data manually, only enter one X-Value per line.
Replicates can be graphed simultaneously. Graph will generate error bars based on the standard error of the mean (SEM). Simply paste or enter all data columns to begin. Format should be as follows:
Users can graph up to three data sets on the same graph for comparison purposes. To add a new data set , press the "+" tab above the data entry area.Data sets can be renamed by double clicking the tab. Each dataset will generate a corresponding IC50 value as well as the equation for the best fit line.
2. Verify your data is accurate in the table that appears.
3. Press the "Calculate IC50" button to display results, including calculations and graph.
Replicates can be graphed simultaneously. Graph will generate error bars based on the standard error of the mean (SEM). Simply paste or enter all data columns to begin. Format should be as follows:
Concentration | Response 1 | Response 2 | ... |
C1 | R11 | R21 | ... |
C2 | R12 | R22 | ... |
C3 | R13 | R23 | ... |
... | ... | ... | ... |
Users can graph up to three data sets on the same graph for comparison purposes. To add a new data set , press the "+" tab above the data entry area.Data sets can be renamed by double clicking the tab. Each dataset will generate a corresponding IC50 value as well as the equation for the best fit line.
2. Verify your data is accurate in the table that appears.
3. Press the "Calculate IC50" button to display results, including calculations and graph.
Data Entry
+
Additional Information
The Quest Graph™ IC50 Calculator attempts to model an experimental set using a four parameter logistic regression model, so called because it has four key parameters in an equation of the form:
This model typically resolves as a sigmoid function, or "S"-shaped curve. For biological promotion, the Hill coefficient of the equation will be (-) negative, with the slope of the curve rising ("S"). For biological inhibition, the Hill coefficient of the equation will be (+) positive, with the slope of the curve falling ("Ƨ").
With regards to IC50, the sigmoid function itself is a special case of the log-logistic distribution, which is part of a broader family of logistic distributions and functions. In contrast to standard logistic distributions, however, a primary distinction of this calculator is that it does not necessitate prior normalization of data, nor does it enforce these boundaries in the modeling of an experimental set. That is to say, in a standard logistic distribution, the response values (Y) range from 0 to 1 probability values. This is typically what is seen in probit/logit analysis and what is commonly used when modeling population survival rates. In this calculator, response values can be any positive real number, which may result in regression models which do not adhere to the 0 to 1 logistic distribution boundaries. This is especially the case where the controls of an experimental set do not make clear the upper and lower bounds of the data. In such cases, it is not uncommon to generate a regression model which extends far into the negative Y-axis or rises exponentially.
Because negative response values are typically incoherent in biological contexts, it is often desirable to analytical restrict regression models to the positive response domain. This can be achieved computational by fixing the minimum response value to zero. This reduces the four parameter logistic model into a three parameter logistic model with the simplified equation as follows:
With this form, the regression model has a lower-bounds fixed at zero, eliminating any models which may otherwise extend into the negative response domain.
There are two final points to make about this calculator. The first is that the four parameter logistic curve is a symmetric regression model around the inflection point, that is, the IC50. Roughly translated, this implies that the shape of the sigmoid function on one side of the inflection point will mirror that of the other side. In order to model an experimental set which is asymmetric in nature, a five parameter logistic curve is required. Second, it is inadequate to utilize R2 when discussing the goodness of fit of a four parameter regression model. As has been demonstrated in several papers, R2 can be used when describing linear regression models, but fails to capture the degree of noise and variability in non-linear models.
For additional reading, please see the following:
Y = Min +
Max − Min
1 + (
X
IC50
)
Hill coefficientThis model typically resolves as a sigmoid function, or "S"-shaped curve. For biological promotion, the Hill coefficient of the equation will be (-) negative, with the slope of the curve rising ("S"). For biological inhibition, the Hill coefficient of the equation will be (+) positive, with the slope of the curve falling ("Ƨ").
With regards to IC50, the sigmoid function itself is a special case of the log-logistic distribution, which is part of a broader family of logistic distributions and functions. In contrast to standard logistic distributions, however, a primary distinction of this calculator is that it does not necessitate prior normalization of data, nor does it enforce these boundaries in the modeling of an experimental set. That is to say, in a standard logistic distribution, the response values (Y) range from 0 to 1 probability values. This is typically what is seen in probit/logit analysis and what is commonly used when modeling population survival rates. In this calculator, response values can be any positive real number, which may result in regression models which do not adhere to the 0 to 1 logistic distribution boundaries. This is especially the case where the controls of an experimental set do not make clear the upper and lower bounds of the data. In such cases, it is not uncommon to generate a regression model which extends far into the negative Y-axis or rises exponentially.
Because negative response values are typically incoherent in biological contexts, it is often desirable to analytical restrict regression models to the positive response domain. This can be achieved computational by fixing the minimum response value to zero. This reduces the four parameter logistic model into a three parameter logistic model with the simplified equation as follows:
Y =
Max
1 + (
X
IC50
)
Hill coefficientWith this form, the regression model has a lower-bounds fixed at zero, eliminating any models which may otherwise extend into the negative response domain.
There are two final points to make about this calculator. The first is that the four parameter logistic curve is a symmetric regression model around the inflection point, that is, the IC50. Roughly translated, this implies that the shape of the sigmoid function on one side of the inflection point will mirror that of the other side. In order to model an experimental set which is asymmetric in nature, a five parameter logistic curve is required. Second, it is inadequate to utilize R2 when discussing the goodness of fit of a four parameter regression model. As has been demonstrated in several papers, R2 can be used when describing linear regression models, but fails to capture the degree of noise and variability in non-linear models.
For additional reading, please see the following:
- Finney, David John, and F. Tattersfield. Probit analysis. Cambridge University Press; Cambridge, 1952.
- Sebaugh, J. L. (2011). Guidelines for accurate EC50/IC50 estimation. Pharmaceutical statistics, 10(2), 128-134.
- Spiess, A. N., & Neumeyer, N. (2010). An evaluation of R 2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach. BMC pharmacology, 10(1), 6.
Feedback
Have a question or a feature request about this tool? Feel free to reach out to us and let us know! We're always looking for ways to improve!References
This online tool may be cited as follows
MLA | "Quest Graph™ IC50 Calculator." AAT Bioquest, Inc., 28 Jan. 2023, https://www.aatbio.com/tools/ic50-calculator. |
APA | AAT Bioquest, Inc. (2023, January 28). Quest Graph™ IC50 Calculator. AAT Bioquest. https://www.aatbio.com/tools/ic50-calculator. |
This online tool has been cited in 267 publications, including
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells
Authors: Ziganshina, Albina Y and Mansurova, Elina E and Voloshina, Alexandra D and Lyubina, Anna P and Amerhanova, Syumbelya K and Shulaeva, Marina M and Nizameev, Irek R and Kadirov, Marsil K and Bakhtiozina, Leysan R and Semenov, Vyacheslav E and others,
Journal: Molecules (2023): 551
Authors: Ziganshina, Albina Y and Mansurova, Elina E and Voloshina, Alexandra D and Lyubina, Anna P and Amerhanova, Syumbelya K and Shulaeva, Marina M and Nizameev, Irek R and Kadirov, Marsil K and Bakhtiozina, Leysan R and Semenov, Vyacheslav E and others,
Journal: Molecules (2023): 551
Synthesis, Characterization, and Antiproliferative Properties of New Bio-Inspired Xanthylium Derivatives
Authors: Koch, Claudia and Dreav{\u{a}}, Diana-Maria and Todea, Anamaria and P{\'e}ter, Francisc and Medeleanu, Mihai and P{\u{a}}ușescu, Iulia and Samoil{\u{a}}, Corina and S{\^\i}rbu, Ioan Ovidiu
Journal: Molecules (2023): 1102
Authors: Koch, Claudia and Dreav{\u{a}}, Diana-Maria and Todea, Anamaria and P{\'e}ter, Francisc and Medeleanu, Mihai and P{\u{a}}ușescu, Iulia and Samoil{\u{a}}, Corina and S{\^\i}rbu, Ioan Ovidiu
Journal: Molecules (2023): 1102
Nintedanib-$\alpha$V$\beta$6 Integrin Ligand Conjugates Reduce TGF $\beta$-Induced EMT in Human Non-Small Cell Lung Cancer
Authors: Andreucci, Elena and Bugatti, Kelly and Peppicelli, Silvia and Ruzzolini, Jessica and Lulli, Matteo and Calorini, Lido and Battistini, Lucia and Zanardi, Franca and Sartori, Andrea and Bianchini, Francesca
Journal: International Journal of Molecular Sciences (2023): 1475
Authors: Andreucci, Elena and Bugatti, Kelly and Peppicelli, Silvia and Ruzzolini, Jessica and Lulli, Matteo and Calorini, Lido and Battistini, Lucia and Zanardi, Franca and Sartori, Andrea and Bianchini, Francesca
Journal: International Journal of Molecular Sciences (2023): 1475
LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
Authors: Zuo, Tao and Jiang, Ping and Fu, Jun and Zhang, Yongjian
Journal: Therapeutics and Clinical Risk Management (2023): 1--13
Authors: Zuo, Tao and Jiang, Ping and Fu, Jun and Zhang, Yongjian
Journal: Therapeutics and Clinical Risk Management (2023): 1--13
Evaluation of the Effectiveness of Charcoal, Lactobacillus rhamnosus, and Saccharomyces cerevisiae as Aflatoxin Adsorbents in Chocolate
Authors: Hamad, Gamal M and Amer, Amr and El-Nogoumy, Baher and Ibrahim, Mohamed and Hassan, Sabria and Siddiqui, Shahida Anusha and EL-Gazzar, Ahmed M and Khalifa, Eman and Omar, Sabrien A and Abd-Elmohsen Abou-Alella, Sarah and others,
Journal: Toxins (2023): 21
Authors: Hamad, Gamal M and Amer, Amr and El-Nogoumy, Baher and Ibrahim, Mohamed and Hassan, Sabria and Siddiqui, Shahida Anusha and EL-Gazzar, Ahmed M and Khalifa, Eman and Omar, Sabrien A and Abd-Elmohsen Abou-Alella, Sarah and others,
Journal: Toxins (2023): 21
Constituents of Pulicaria inuloides and Cytotoxic Activities of Two Methoxylated Flavonols
Authors: Malarz, Janusz and Michalska, Klaudia and Galanty, Agnieszka and Kiss, Anna Karolina and Stojakowska, Anna
Journal: Molecules (2023): 480
Authors: Malarz, Janusz and Michalska, Klaudia and Galanty, Agnieszka and Kiss, Anna Karolina and Stojakowska, Anna
Journal: Molecules (2023): 480
Antibacterial Activity on Orthopedic Clinical Isolates and Cytotoxicity of the Antimicrobial Peptide Dadapin-1
Authors: Campoccia, Davide and Montanaro, Lucio and Ravaioli, Stefano and Mariani, Valentina and Bottau, Giulia and De Donno, Andrea and Arciola, Carla Renata
Journal: International Journal of Molecular Sciences (2023): 779
Authors: Campoccia, Davide and Montanaro, Lucio and Ravaioli, Stefano and Mariani, Valentina and Bottau, Giulia and De Donno, Andrea and Arciola, Carla Renata
Journal: International Journal of Molecular Sciences (2023): 779
Anti-HIV Potential of Beesioside I Derivatives as Maturation Inhibitors: Synthesis, 3D-QSAR, Molecular Docking and Molecular Dynamics Simulations
Authors: Zhao, Zixuan and Ma, Yinghong and Li, Xiangyuan and Morris-Natschke, Susan L and Sun, Zhaocui and Sun, Zhonghao and Ma, Guoxu and Dong, Zhengqi and Zhao, Xiaohong and Yang, Meihua and others,
Journal: International Journal of Molecular Sciences (2023): 1430
Authors: Zhao, Zixuan and Ma, Yinghong and Li, Xiangyuan and Morris-Natschke, Susan L and Sun, Zhaocui and Sun, Zhonghao and Ma, Guoxu and Dong, Zhengqi and Zhao, Xiaohong and Yang, Meihua and others,
Journal: International Journal of Molecular Sciences (2023): 1430
ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
Authors: Qiu, Heng and Hosking, Christopher and Rothzerg, Emel and Samantha, Ariela and Chen, Kai and Kuek, Vincent and Jin, Haiming and Zhu, Sipin and Vrielink, Alice and Lim, Kevin and others,
Journal: Journal of Biological Chemistry (2023): 102889
Authors: Qiu, Heng and Hosking, Christopher and Rothzerg, Emel and Samantha, Ariela and Chen, Kai and Kuek, Vincent and Jin, Haiming and Zhu, Sipin and Vrielink, Alice and Lim, Kevin and others,
Journal: Journal of Biological Chemistry (2023): 102889
Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric plasma activated media
Authors: Cort{\'a}zar, Osvaldo Daniel and Meg{\'\i}a-Mac{\'\i}as, Ana and Moreno, Sandra and Brun, Alejandro and G{\'o}mez-Casado, Eduardo
Journal: Scientific Reports (2022): 1--12
Authors: Cort{\'a}zar, Osvaldo Daniel and Meg{\'\i}a-Mac{\'\i}as, Ana and Moreno, Sandra and Brun, Alejandro and G{\'o}mez-Casado, Eduardo
Journal: Scientific Reports (2022): 1--12
Theonellamides J and K and 5-cis-Apoa-theopalauamide, Bicyclic Glycopeptides of the Red Sea Sponge Theonella swinhoei
Authors: Hasin, Ohad and Shoham, Shani and Kashman, Yoel and Ilan, Micha and Carmeli, Shmuel
Journal: Marine drugs (2022): 31
Authors: Hasin, Ohad and Shoham, Shani and Kashman, Yoel and Ilan, Micha and Carmeli, Shmuel
Journal: Marine drugs (2022): 31
The role of the guanine nucleotide exchange factors DOCK2 and DOCK5 in acute myeloid leukemia and their interactions with epigenetic regulation
Authors: Attar, Mohammad Nader
Journal: (2022)
Authors: Attar, Mohammad Nader
Journal: (2022)
The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
Authors: Celesia, Adriana and Notaro, Antonietta and Franz{\`o}, Marzia and Lauricella, Marianna and D’Anneo, Antonella and Carlisi, Daniela and Giuliano, Michela and Emanuele, Sonia
Journal: Biomedicines (2022): 1994
Authors: Celesia, Adriana and Notaro, Antonietta and Franz{\`o}, Marzia and Lauricella, Marianna and D’Anneo, Antonella and Carlisi, Daniela and Giuliano, Michela and Emanuele, Sonia
Journal: Biomedicines (2022): 1994
The Discovery of Antibiotics from Soil and the Characterization of Darobactin Analogs
Authors: Green, Robert
Journal: (2022)
Authors: Green, Robert
Journal: (2022)
Targeted Modification and Structure-Activity Study of GL-29, an Analogue of the Antimicrobial Peptide Palustrin-2ISb
Authors: Liu, Siyan and Lin, Yaxian and Liu, Jiachen and Chen, Xiaoling and Ma, Chengbang and Xi, Xinping and Zhou, Mei and Chen, Tianbao and Burrows, James F and Wang, Lei
Journal: Antibiotics (2022): 1048
Authors: Liu, Siyan and Lin, Yaxian and Liu, Jiachen and Chen, Xiaoling and Ma, Chengbang and Xi, Xinping and Zhou, Mei and Chen, Tianbao and Burrows, James F and Wang, Lei
Journal: Antibiotics (2022): 1048
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with R-Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines
Authors: Wr{\'o}bel, Konrad and Wo{\l}owiec, Stanis{\l}aw and Markowicz, Joanna and Wa{\l}ajtys-Rode, El{\.z}bieta and Uram, {\L}ukasz
Journal: Cancers (2022): 714
Authors: Wr{\'o}bel, Konrad and Wo{\l}owiec, Stanis{\l}aw and Markowicz, Joanna and Wa{\l}ajtys-Rode, El{\.z}bieta and Uram, {\L}ukasz
Journal: Cancers (2022): 714
Synthesis and Properties of $\alpha$-Mangostin and Vadimezan Conjugates with Glucoheptoamidated and Biotinylated 3rd Generation Poly (amidoamine) Dendrimer, and Conjugation Effect on Their Anticancer and Anti-Nematode Activities
Authors: Markowicz, Joanna and Wo{\l}owiec, Stanis{\l}aw and Rode, Wojciech and Uram, {\L}ukasz
Journal: Pharmaceutics (2022): 606
Authors: Markowicz, Joanna and Wo{\l}owiec, Stanis{\l}aw and Rode, Wojciech and Uram, {\L}ukasz
Journal: Pharmaceutics (2022): 606
Synergistic Effect of Taxol and Vincristine Against MCF-7 Cell Line
Authors: Zandi, Mohammad
Journal: Gene, Cell and Tissue (2022)
Authors: Zandi, Mohammad
Journal: Gene, Cell and Tissue (2022)
Structure--Activity Relationship of the Thiacalix [4] arenes Family with Sulfobetaine Fragments: Self-Assembly and Cytotoxic Effect against Cancer Cell Lines
Authors: Yakimova, Luidmila and Kunafina, Aisylu and Nugmanova, Aigul and Padnya, Pavel and Voloshina, Alexandra and Petrov, Konstantin and Stoikov, Ivan
Journal: Molecules (2022): 1364
Authors: Yakimova, Luidmila and Kunafina, Aisylu and Nugmanova, Aigul and Padnya, Pavel and Voloshina, Alexandra and Petrov, Konstantin and Stoikov, Ivan
Journal: Molecules (2022): 1364
Sterically Hindered Quaternary Phosphonium Salts (QPSs): Antimicrobial Activity and Hemolytic and Cytotoxic Properties
Authors: Ermolaev, Vadim V and Arkhipova, Daria M and Miluykov, Vasili A and Lyubina, Anna P and Amerhanova, Syumbelya K and Kulik, Natalia V and Voloshina, Alexandra D and Ananikov, Valentine P
Journal: International journal of molecular sciences (2022): 86
Authors: Ermolaev, Vadim V and Arkhipova, Daria M and Miluykov, Vasili A and Lyubina, Anna P and Amerhanova, Syumbelya K and Kulik, Natalia V and Voloshina, Alexandra D and Ananikov, Valentine P
Journal: International journal of molecular sciences (2022): 86
Sodium metabisulfite in dried plum and its cytotoxic effects on K-562 and L-929 normal cell lines
Authors: Ghasemi, Ahmad and Salari, Amir and Kalantarmahdavi, Mahboube and Amiryousefi, Mohammad Reza
Journal: Journal of Food Science (2022)
Authors: Ghasemi, Ahmad and Salari, Amir and Kalantarmahdavi, Mahboube and Amiryousefi, Mohammad Reza
Journal: Journal of Food Science (2022)
Self-Assembling Metallocomplexes of the Amphiphilic 1, 4-Diazabicyclo [2.2. 2] octane Derivative as a Platform for the Development of Nonplatinum Anticancer Drugs
Authors: Zakharova, Lucia Ya and Voloshina, Alexandra D and Ibatullina, Marina R and Zhiltsova, Elena P and Lukashenko, Svetlana S and Kuznetsova, Darya A and Kutyreva, Marianna P and Sapunova, Anastasiia S and Kufelkina, Anna A and Kulik, Natalia V and others,
Journal: ACS Omega (2022)
Authors: Zakharova, Lucia Ya and Voloshina, Alexandra D and Ibatullina, Marina R and Zhiltsova, Elena P and Lukashenko, Svetlana S and Kuznetsova, Darya A and Kutyreva, Marianna P and Sapunova, Anastasiia S and Kufelkina, Anna A and Kulik, Natalia V and others,
Journal: ACS Omega (2022)
Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-Ones for Pharmaceuticals
Authors: Burgart, Yanina V and Elkina, Natalia A and Shchegolkov, Evgeny V and Krasnykh, Olga P and Makhaeva, Galina F and Triandafilova, Galina A and Solodnikov, Sergey Yu and Boltneva, Natalia P and Rudakova, Elena V and Kovaleva, Nadezhda V and others,
Journal: Molecules (2022): 59
Authors: Burgart, Yanina V and Elkina, Natalia A and Shchegolkov, Evgeny V and Krasnykh, Olga P and Makhaeva, Galina F and Triandafilova, Galina A and Solodnikov, Sergey Yu and Boltneva, Natalia P and Rudakova, Elena V and Kovaleva, Nadezhda V and others,
Journal: Molecules (2022): 59
Potential Anticancer Agents against Melanoma Cells Based on an As-Synthesized Thiosemicarbazide Derivative
Authors: Kozyra, Pawe{\l} and Korga-Plewko, Agnieszka and Karczmarzyk, Zbigniew and Hawry{\l}, Anna and Wysocki, Waldemar and Cz{\l}apski, Micha{\l} and Iwan, Magdalena and Ostrowska-Le{\'s}ko, Marta and Fornal, Emilia and Pitucha, Monika
Journal: Biomolecules (2022): 151
Authors: Kozyra, Pawe{\l} and Korga-Plewko, Agnieszka and Karczmarzyk, Zbigniew and Hawry{\l}, Anna and Wysocki, Waldemar and Cz{\l}apski, Micha{\l} and Iwan, Magdalena and Ostrowska-Le{\'s}ko, Marta and Fornal, Emilia and Pitucha, Monika
Journal: Biomolecules (2022): 151
PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistance
Authors: Tabury, Kevin and Monavarian, Mehri and Listik, Eduardo and Shelton, Abigail K and Choi, Alex Seok and Quintens, Roel and Arend, Rebecca C and Hempel, Nadine and Miller, C Ryan and Gy{\"o}rrfy, Bal{\'a}zs and others,
Journal: bioRxiv (2022)
Authors: Tabury, Kevin and Monavarian, Mehri and Listik, Eduardo and Shelton, Abigail K and Choi, Alex Seok and Quintens, Roel and Arend, Rebecca C and Hempel, Nadine and Miller, C Ryan and Gy{\"o}rrfy, Bal{\'a}zs and others,
Journal: bioRxiv (2022)
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2
Authors: Pasquero, Selina and Gugliesi, Francesca and Griffante, Gloria and Dell’Oste, Valentina and Biolatti, Matteo and Albano, Camilla and Bajetto, Greta and Delbue, Serena and Signorini, Lucia and Dolci, Maria and others,
Journal: Antiviral Research (2022): 105278
Authors: Pasquero, Selina and Gugliesi, Francesca and Griffante, Gloria and Dell’Oste, Valentina and Biolatti, Matteo and Albano, Camilla and Bajetto, Greta and Delbue, Serena and Signorini, Lucia and Dolci, Maria and others,
Journal: Antiviral Research (2022): 105278